Cargando…
Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072428/ http://dx.doi.org/10.1371/annotation/71208a01-eb32-469c-96ab-8d5e3c497fce |
| _version_ | 1782201555672367104 |
|---|---|
| author | Pathan, Ansar A. Sander, Clare R. Fletcher, Helen A. Poulton, Ian Alder, Nicola C. Beveridge, Natalie E. R. Whelan, Kathryn T. Hill, Adrian V. S. McShane, Helen |
| author_facet | Pathan, Ansar A. Sander, Clare R. Fletcher, Helen A. Poulton, Ian Alder, Nicola C. Beveridge, Natalie E. R. Whelan, Kathryn T. Hill, Adrian V. S. McShane, Helen |
| author_sort | Pathan, Ansar A. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3072428 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-30724282011-04-14 Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials Pathan, Ansar A. Sander, Clare R. Fletcher, Helen A. Poulton, Ian Alder, Nicola C. Beveridge, Natalie E. R. Whelan, Kathryn T. Hill, Adrian V. S. McShane, Helen PLoS One Correction Public Library of Science 2011-02-26 /pmc/articles/PMC3072428/ http://dx.doi.org/10.1371/annotation/71208a01-eb32-469c-96ab-8d5e3c497fce Text en Public Library of Science. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| spellingShingle | Correction Pathan, Ansar A. Sander, Clare R. Fletcher, Helen A. Poulton, Ian Alder, Nicola C. Beveridge, Natalie E. R. Whelan, Kathryn T. Hill, Adrian V. S. McShane, Helen Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials |
| title | Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials |
| title_full | Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials |
| title_fullStr | Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials |
| title_full_unstemmed | Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials |
| title_short | Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials |
| title_sort | correction: boosting bcg with recombinant modified vaccinia ankara expressing antigen 85a: different boosting intervals and implications for efficacy trials |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072428/ http://dx.doi.org/10.1371/annotation/71208a01-eb32-469c-96ab-8d5e3c497fce |
| work_keys_str_mv | AT pathanansara correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials AT sanderclarer correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials AT fletcherhelena correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials AT poultonian correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials AT aldernicolac correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials AT beveridgenatalieer correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials AT whelankathrynt correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials AT hilladrianvs correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials AT mcshanehelen correctionboostingbcgwithrecombinantmodifiedvacciniaankaraexpressingantigen85adifferentboostingintervalsandimplicationsforefficacytrials |